Engineered Listeria monocytogenes as an AIDS vaccine

Vaccine

Volumn 20, Issue 15, 2002, Pages 2007-2010

  Lieberman, Judy ^a   Frankel, Fred R ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

D Ala; HIV; Listeria monocytogenes; Lmdd gag; Mucosal immunity; Oral vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG SAFETY; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; LISTERIA MONOCYTOGENES; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AIDS VACCINES; ANIMALS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENES, GAG; GENES, NEF; GENETIC ENGINEERING; GENETIC VECTORS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; INFANT, NEWBORN; LISTERIA MONOCYTOGENES; MALE; MICE; PREGNANCY; SAFETY; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0037029929     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00088-9     Document Type: Article

References (28)

1. H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2K structure involved is coded by a single cistron defined by H-2Kb mutant mice
2. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice
3. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection
4. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope
5. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication
6. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide
7. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge
8. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours
9. Recombinant Listeria monocytogenes cancer vaccines
10. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity
11. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes
12. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines
13. Interaction of Listeria monocytogenes with mouse dendritic cells
14. Compartmentalization of bacterial antigens: Differential effects on priming of CD8 T cells and protective immunity
15. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 gag protein by using Listeria monocytogenes as a live vaccine vector
16. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D
17. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes
18. Reduction in the incidence of human listeriosis in the United States. effectiveness of prevention efforts? The Listeriosis Study Group
19. Dual roles of plcA in Listeria monocytogenes pathogenesis
20. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes
21. Stimulation of protective CD8+ T lymphocytes by vaccination with nonliving bacteria
22. Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino acid substitutions in listeriolysin O
23. Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth
24. Induction of protective CD8+ T lymphocytes by an attenuated Listeria monocytogenes actA mutant
25. Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: A study with the nucleoprotein of the lymphocytic choriomeningitis virus
26. Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth
27. Feeding trials of Listeria monocytogenes with a nonhuman primate model
28. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens